The histamine releasing factor (HRF) molecule has been identified by researchers at La Jolla Institute for Allergy & Immunology, as a potential target for developing novel therapies for numerous allergic reactions, including asthma. The study is published online in the Journal of Clinical Investigation. In addition, the team, led by Toshiaki Kawakami, M.D., Ph.D., is the first to illuminate the HRF molecule in promoting asthma and some allergies, including identifying its receptor - a significant discovery that answers a vital question in the allergy research community. Juan Rivera, M...
More...
More...